Evolution of signaling molecules opens door to new sepsis therapy approaches

Small infections can be fatal: Millions of people die each year from sepsis, an overreaction of the immune system. A new immune signaling molecule, designed by a research team from the Technical University of Munich (TUM), now provides the basis for potential new approaches in sepsis therapy.

Quell: IDW Informationsdienst Wissenschaft